Chronotropic Incompetence (CI) Diagnostic Algorithm in Heart Failure Patients

January 23, 2020 updated by: Medtronic Cardiac Rhythm and Heart Failure

Investigation of the Chronotropic Incompetence Diagnostic Algorithm in Heart Failure Patients

This study is to collect human activity and electrocardiogram (ECG) data from heart failure (HF) patients to aid in the development of a novel chronotropic incompetence (CI) algorithm designed to diagnose CI in patients with HF.

Study Overview

Status

Terminated

Conditions

Detailed Description

The Investigation of the Chronotropic Incompetence Diagnostic Algorithm in Heart Failure Patients (CI Algorithm Study) is an acute data collection study using market released actigraphy devices (wGT3X-BT) and holter devices (DR 180) to measure study subjects' daily activities and surface ECG data simultaneously. The data will be analyzed to develop an algorithm to diagnose CI in patients with HF.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200020
        • Ruijin Hospital Luwan Branch, Shanghai JiaoTong University School of Medicine
      • Shanghai, Shanghai, China, 200233
        • Sixth people's Hospital Affiliated to Shanghai Jiaotong University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria for the case group:

  • Patient is greater than 18 years of age and less than 70 years of old.
  • Patient is willing and able to give informed consent.
  • Patient has been diagnosed with stable chronic HF according to European Society of Cardiology 2012 HF guidance.
  • New York Heart Association class I- III, including with HF with preserved ejection fraction and HF with reduced ejection fraction patients.
  • Patients can perform moderate exercise.
  • Left ventricular ejection fraction less than 55% but greater than 35%.

Inclusion criteria for the control group:

  • Subject is greater than 18 years of age and less than 70 years of old.
  • Subject is willing and able to give informed consent.

Exclusion criteria for the case group:

  • Patient is unable or unwilling to sign the patient informed consent.
  • Patient has implantable pacemaker, Implantable cardiovert defibrillator (ICD) or cardiac resynchronize therapy (CRT) device.
  • Patient has at least one pacemaker, ICD or CRT indications.
  • Patients has persistent atrial fibrillation (AF).
  • Patient whose hear rate baseline at the rest is greater than 95 beats per minutes (BPM).
  • Patient has contraindications for cardio-pulmonary exercise testing, including but not limited to, unstable angina, decompensated heart failure, active pericarditis or myocarditis and ECG ST-segment shift > 2mm at the resting.
  • New York Heart Association Class IV.
  • Less than 45 days after myocardial infarction.
  • Less than 3 months after acute heart failure.
  • Patient has uncontrolled hypertension.
  • Patient is pregnant.
  • Patient has a medical condition that would limit study participation.
  • Patient is enrolled in a concurrent study that may affect the outcome of this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Case group
At the beginning of the study, each subject of the case group will complete echo examination and related lab test for BNP. During the study, each subject will have a six minutes' walk test and 24 hour ambulatory monitoring while having an ActiGraph device placed on his/her wrist and a Holter device with ECG electrodes placed on his/her chest. The treadmill test is optional to patients per physicians' instruction and/or patients' own judgment. It would be performed at the end of the study if chosen.
Other Names:
  • Standard of Care Diagnostic Testing
Placebo Comparator: Control group
Each subject of the control group will do the same test and examination with the subjects in the case group.
Other Names:
  • Standard of Care Diagnostic Testing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronotropic Incompetence Index of Patients With Heart Failure Disease
Time Frame: Implant through 6 months

Compare chronotropic incompetence index in patients with heart failure using an interventional diagnostic algorithm compared to standard of care diagnostics.

Chronotropic Index = [achieved maximal HR-resting HR]/[age-predicted maximal HR-resting HR]. Normal CI is ~ 1 with low CI considered < 0.8

Measurement described as: Chronotropic index=HRR/metabolic reserve.

Implant through 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jianrong Zhao, MD, Ruijin Hospital Luwan Branch, Shanghai JiaoTong University School of Medicine
  • Principal Investigator: Jinbo Li, MD, Sixth people's Hospital Affiliated to Shanghai Jiaotong University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2014

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

May 16, 2014

First Submitted That Met QC Criteria

February 3, 2015

First Posted (Estimate)

February 9, 2015

Study Record Updates

Last Update Posted (Actual)

February 5, 2020

Last Update Submitted That Met QC Criteria

January 23, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CI in Heart Failure Study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Chronotropic Incompetence Diagnostic Algorithm

Subscribe